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Vegard B Wyller1,2* and Ingrid B Helland2Abstract
Chronic Fatigue Syndrome (CFS) is characterized by severe impairment and multiple symptoms. Autonomic
dysregulation has been demonstrated in several studies. We aimed at exploring the relationship between indices of
autonomic cardiovascular control, the case definition from Centers for Disease Control and Prevention (CDC
criteria), important clinical symptoms, and disability in adolescent chronic fatigue syndrome. 38 CFS patients aged
12–18 years were recruited according to a wide case definition (ie. not requiring accompanying symptoms) and
subjected to head-up tilt test (HUT) and a questionnaire. The relationships between variables were explored with
multiple linear regression analyses. In the final models, disability was positively associated with symptoms of
cognitive impairments (p<0.001), hypersensitivity (p<0.001), fatigue (p=0.003) and age (p=0.007). Symptoms of
cognitive impairments were associated with age (p=0.002), heart rate (HR) at baseline (p=0.01), and HR response
during HUT (p=0.02). Hypersensitivity was associated with HR response during HUT (p=0.001), high-frequency
variability of heart rate (HF-RRI) at baseline (p=0.05), and adherence to the CDC criteria (p=0.005). Fatigue was
associated with gender (p=0.007) and adherence to the CDC criteria (p=0.04). In conclusion, a) The disability of CFS
patients is not only related to fatigue but to other symptoms as well; b) Altered cardiovascular autonomic control is
associated with certain symptoms; c) The CDC criteria are poorly associated with disability, symptoms, and indices
of altered autonomic nervous activity.
Keywords: Adolescents, Chronic fatigue syndrome, Autonomic cardiovascular control, Diagnostic criteriaBackground
Chronic fatigue syndrome (CFS) is a disabling condition
that seriously affects school-attendance and social acti-
vities [1]. The prevalence among 8–17 years olds has
been reported as high as 1% [2,3]; thus, CFS constitutes
a substantial health problem in adolescence. As yet, no
effective pharmacotherapy exists.
CFS patients report a great variety of bodily symptoms.
Generally, their experience of overwhelming fatigue is
assumed to be the single most important factor for their
substantial impairments. However, it is conceivable that* Correspondence: brwylle@online.no
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distribution, and reproduction in any mediumother symptoms might equally impact on their abilities. If
so, this might be important for clinical management and
suggest alternative treatment strategies. The relationship
between symptoms and disability has rarely been explored
in previous CFS reports.
Certain characteristic CFS symptoms, such as light-
headedness, indicate alterations of autonomic nervous
activity. Indeed, experimental studies have demonstrated
distinct abnormalities in cardiovascular autonomic con-
trol [4,5]. Previous reports from our institution have
documented higher blood pressure and heart rate at rest
among adolescent CFS patients as compared to healthy
controls and a stronger increase of these variables upon
orthostatic stress [6-10]. Similarly, ambulatory measure-
ments of blood pressure and heart rate indicate higher
nocturnal values among CFS patients as compared toentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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abnormal autonomic nervous activity might constitute
an important aspect of CFS pathophysiology [12,13]. If
so, a relationship between clinical symptoms and indices
of altered autonomic cardiovascular control should be
demonstrable, which in turn might provide a basis for de-
velopment of novel therapies as well as a diagnostic test.
As yet, no CFS biomarker has any diagnostic utility;
thus, the diagnosis is solely based upon patients’ reports
of symptoms. Several different case definitions exist,
reflecting unsettled controversies in the scientific com-
munity [14,15]. The definition from the International
Chronic Fatigue Syndrome Study Group at the Centers
for Disease Control and Prevention (commonly referred
to as the CDC-definition) appears to be most frequently
used [16]. This definition requires at least six months of
unexplained chronic or relapsing fatigue of new onset,
severely affecting daily activities, as well as four or more
of eight specific accompanying symptoms (headache,
muscle pain, joint pain, sore throat, tender lymph nodes,
impaired memory or concentration, unrefreshing sleep,
and malaise after exertion). The validity of this definition
has been questioned [17-20]. For instance, a formal fac-
tor analysis of symptoms in a broadly defined group of
chronic fatigued patients did not show a strong corres-
pondence with the CDC accompanying symptoms [19].
Accordingly, a recent study by Sullivan and co-workers
based upon the Swedish twin registry concluded that there
was no empirical support for the requirement of four out
of eight CDC accompanying symptoms [20]. In adoles-
cents, few studies of validity have been conducted. Thus,
one purpose of this study is to explore the informative
value of the CDC-definition within a more broadly defined
population of adolescent chronic fatigue sufferers; this ap-
proach has been recommended by others [20,21].
In 2007, we launched an observational prospective
study on the clinical course of adolescent CFS. The
changes of different clinical features with time have been
reported elsewhere [22]. However, little is known about
the interrelation of pathophysiological characteristics,
patients’ experiences, and functional abilities. Thus, the
overall aim of the present report is to explore the rela-
tionship between indices of autonomic cardiovascular
control, the CDC case definition, important clinical
symptoms, and disability in adolescent chronic fatigue
syndrome at a single time point.
Methods
Subjects
During the study period from August 2007 to April
2009, adolescent CFS patients aged 12 – 18 years were
recruited from the Paediatric outpatient clinic, Oslo Uni-
versity Hospital, Rikshospitalet, Norway, which serves as
a national referral center for children and adolescentswith CFS. Prior to referral, they had been tentatively given
the diagnosis CFS at local hospitals. The Norwegian cli-
nical guidelines for diagnosis of adolescent CFS are in ac-
cordance with the recommendations from The Royal
College of Paediatrics and Child Health [1] and the Na-
tional Institute for Health and Clinical Excellence [23]. In
short, a diagnosis of CFS is made if the patients suffer
from three or more consecutive months of unexplained
disabling fatigue worsened by physical or mental exertion.
No accompanying symptoms are required.
At our referral centre, diagnostic confirmation was
established by means of a thorough and standardized set
of investigations, ruling out differential diagnosis such as
autoimmune, endocrine, neurologic or psychiatric disor-
ders (including depression). All patients included in this
study fulfilled our clinical definition of CFS. In addition,
inclusion in this study required no other chronic disorders,
no permanent use of pharmaceuticals, and no current
demanding life event that might explain the fatigue.
Thus, the inclusion criteria in this study are wider than
the CDC criteria. This approach is in line with findings
from recent validation studies [19,20], and has also been
shown to be feasible in previous studies from our insti-
tution [6-11]. Subgrouping of the participants according
to the CDC case definition was performed post hoc,
based on questionnaire results (cf. below). The main rea-
son for not adhering to the CDC case definition was too
few accompanying symptoms.Study protocol
CFS patients were invited to an experimental session
(consisting of head-up tilt-test (HUT) and a question-
naire) at our institution. One week prior to the experi-
ments, all participants were instructed not to drink
beverages containing alcohol or caffeine, not to take any
drugs, and not to use tobacco products. Patients were
summoned for a second visit 3–17 months after the first
experimental session; the results from this follow-up visit
have been reported elsewhere [22]. Written, informed
consent was obtained from all participants and their par-
ents. The study was conducted in accordance with the
Declaration of Helsinki and was approved by the Regional
committee for ethics in medical research.Questionnaire
The Fatigue Severity Scale (FSS) [24], which is a vali-
dated instrument for assessing fatigue, was translated
into Norwegian by one of the authors (VBW) and
slightly modified in order to fit our particular age group.
The modified FSS consists of 7 items having a 1–5
Likert scale (agree/disagree). Examples of single items
are: “I get exhausted from physical activity” and “Fatigue
is among my three most troublesome symptoms.”
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sing the frequency of a wide range of common CFS symp-
toms (including the accompanying symptoms of the CDC
case definition) and impairments (such as school absen-
teeism) on 1–5 Likert scales. These questions were based
upon our clinical experience and have also proven feasible
in previous studies from our institution [7,9].
Head-up tilt-test (HUT)
HUT was undertaken according to a revised protocol as
described elsewhere [7]. The feasibility of this protocol
for studying adolescent CFS patients has been demon-
strated in several previous studies [6-8]. In particular,
the low tilt angle (20°) does not normally precipitate syn-
cope, which is otherwise a common problem among
adolescents being subjected to stronger orthostatic chal-
lenges [25]. Still, 20° head-up tilt is sufficient to demon-
strate hemodynamic alterations among CFS patients
compared to healthy controls.
HUT was performed at daytime between 8 a.m. and 3
p.m. under calm conditions, dimmed lights, and a stable
room-temperature of 23 - 25°C. Patients were attached
to the Task Force MonitorW (Model 3040i, CNSystems
Medizintechnic, Graz, Austria); a combined hardware
and software device for noninvasive continuous record-
ing of cardiovascular variables [26]. They were posi-
tioned horizontally on a tilt-table with foot-board
support (Model 900–00, CNS-systems Medizintechnik,
Graz, Austria) and had a safety strap over the waist.






















Figure 1 Analytical model for the multivariate linear regression analy
associated with variables “higher” up in the hierarchy.up tilted 20° for 15 minutes, followed by another 5 minutes
epoch in the horizontal position. Subjects did not speak
and were not spoken to.
Instantaneous heart rate (HR) was obtained from the
R-R interval (RRI) of the electrocardiogram. Photoplethys-
mography on the right middle finger was used to obtain a
non-invasive, continuous recording of arterial blood pres-
sure. This method correlates satisfactorily with invasive
pressure measurements [27] and has been validated in
adolescents and children [28]. Impedance cardiography
was used to obtain a continuous recording of the temporal
derivate of the transthoracic impedance (dZ/dt) [29]; the
impedance recordings are not reported in this article.
All recorded signals were on-line transferred to the
built-in recording computer of the Task Force MonitorW
that was running software for real-time data acquisition.
RRI was subjected to spectral analyses using an adaptive
autoregressive algorithm for calculating spectral power
densities in the low-frequency (LF) (0.04 – 0.15 Hz) and
high-frequency (HF) ranges (0.15 – 0.4 Hz). HF-RRI is
considered an index of parasympathetic sinus node modu-
lation, whereas LF-RRI is related to the combined in-
fluence of sympathetic and parasympathetic nervous
activity on the sinus node [26]. Beat-to-beat mean arterial
blood pressure (MBP) was calculated by numerical integra-
tion of the recorded instantaneous blood pressure signal.
Data analysis
Data were exported to Microsoft Excel for further
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ses. We assumed that every variable on a “lower” level could be
Table 1 Variables subjected to linear regression analyses among CFS patients
CFS-patients Healthy controls*
(n = 33)Overall (n = 38) CDC+ (n=27) CDC– (n = 11)
Level 1, background and cardiovascular
Female gender 30 (79 %) 23 (85 %) 7 (64 %) 19 (58 %)
Mean (CI) Mean (CI)
Age (years) 15 15 15 15
(14.4 to 15.5) (14.2 to 15.7) (14.2 to 16.0) (14.5 to 15.8)
BMI (kg/m2) 22.3 22.3 22.2 20.6
(20.8 to 23.8) (20.7 to 23.9) (18.5 to 26.0) (19.7 to 21.5)
Fatigue duration (months) 24 25 23
(20 to 28) (19 to 30) (18 to 28)
MAP baseline (mm Hg)** 82.2 83.1 79.8 80.0
(79.4 to 84.9) (79.9 to 86.4) (73.8 to 85.8) (77.8 to 82.3)
HR baseline (beats/min)** 72.7 73.7 70.4 66.8
(68.9 to 76.6) (68.9 to 78.5) (63.0 to 77.7) (63.2 to 70.4)
LF-RRI baseline (nu) ** 38.3 37.2 40.9 40.8
(32.3 to 44.2) (29.6 to 44.9) (30.7 to 51.1) (34.5 to 47.1)
HF-RRI baseline (nu) ** 61.7 62.8 59.1 59.2
(55.8 to 67.7) (55.1 to 70.4) (48.9 to 69.3) (52.9 to 65.5)
LF-RRI baseline (ms2) ** 600 478 899 963
(331 to 868) (280 to 677) (29 to 1768) (608 to 1318)
HF-RRI baseline (ms2) ** 1120 1038 1319 1859
(700 to 1539) (606 to 1470) (186 to 2452) (964 to 2753)
Delta MAP (mm Hg)** 5.4 4.3 7.8 −0.2
(3.8 to 6.9) (2.6 to 6.1) (4.8 to 10.9) (−1.4 to 1.0)
Delta HR (beats/min)** 4.0 4.7 2.3 1.0
(2.3 to 5.7) (2.5 to 6.8) (−0.9 to 5.6) (−0.3 to 2.3)
Delta LF-RRI (nu) ** 8.4 8.7 7.8 −1.2
(3.8 to 13.1) (2.6 to 14.7) (0.3 to 15.4) (−4.7 to 2.3)
Delta HF-RRI (nu) ** −8.4 −8.7 −7.8 1.2
(−13.1 to −3.8) (−14.7 to −2.6) (−15.4 to −0.3) (−2.3 to 4.7)
Delta LF-RRI (ms2) ** −127 −16 −398 −262
(−329 to 76) (−166 to 134) (−1042 to 247) (−446 to −77)
Delta HF-RRI (ms2) ** −372 −266 −632 −456
(−618 to −126) (−458 to −74) (−1412 to 147) (−782 to −131)
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Altered peripheral circulationb 2.6
(2.2 to 3.1)








Altered muscle control 1.6
(1.2 to 2.0)
Level 3, function (1–5 scale)
Disabilitye 2.9
(2.7 to 3.1)
*Although not the aim of this article, reference values from healthy control subjects are displayed for clarity. Details concerning this reference material have been
described elsewhere [7].**Obtained from 20o head up tilt test. †Fatigue severity scale [23]. ‡Mean of the following items: Difficult to concentrate; difficult to
remember. §Mean of: Sensitivity towards sounds; sensitivity towards light. aMean of: Headache; muscle pain; joint pain. bMean of: Pale hands and feet; pale face.
cMean of: Upright dizziness; palpitations. dMean of: Enlarged cervical lymph nodes; sensation of fever. eMean of: School attendance; homework; school physical
activity; leisure activity; being with friends; being with family; going outdoors; getting up from bed.
CI=confidence interval. CDC=Centers for disease control and prevention. CDC+ = adherence to CDC diagnostic criteria. CDC– = not adhering to CDC diagnostic
criteria. BMI=body mass index. MAP=mean arterial pressure. HR=heart rate. LF-RRI=low-frequency variability of RR-interval (i.e. heart rate). HF-RRI=high-frequency
variability of RR-interval (i.e. heart rate). n.u.=normalized units.
In order to avoid the methodological problem of multiple testing, no statistical tests have been performed.
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based upon assumptions about underlying mechanisms;
for instance, items regarding problems of memory and
problems of concentration were both assumed to ad-
dress cognitive alterations in CFS [7,9]. The arithme-
tical mean was calculated for variables consisting of
more than one item. Likewise, a Fatigue severity score
was created by taking the arithmetical mean across all
7 items from FSS [24]. Finally, a disability score was
defined as the arithmetical mean across 8 items
addressing different aspects of impairment and mal-
functioning: School attendance, homework, school
physical activity, leisure activity, being with friends,
being with family, going outdoors, and getting up
from bed.
From each experimental run of HUT, we calculated
the median of all variables in two epochs: From 270 to
30 seconds prior to tilt (Baseline) and from 300 to 540
seconds after being tilted (Tilt). We also computed delta
values (Tilt – Baseline), which reflect the cardiovascular
response to the tilt maneuver. This method of analyzing
results from HUT has successfully been used in previous
projects from our institution [6-8].Statistical analyses
Statistical analyses were performed using SPSS software
(SPSS Inc., Chicago, Ill.). Based upon present evidence, we
constructed an analytical model as outlined in Figure 1.
We assumed that every variable on a “lower” level could
be associated with variables “higher” up in the hierarchy.
The potential relationship between variables was first
explored in bivariate linear regression analyses, and then
subjected to multivariate linear regression analyses. The
selection of variables in the multivariate models was based
upon results from bivariate analyses, their impact on the
coefficients of the other variables, and their theoretical
plausibility. In each multivariate model, the distribution of
residuals was assessed for normality.
Results are reported as regression coefficients (Bs)
with 95% confidence intervals (CIs). A p-value < 0.05
was considered statistically significant.
Results and discussion
Initially, 47 CFS patients were included in the study. Of
these, 38 patients (8 males, 30 females; mean age 15
years) completed the study protocol and were thus avail-
able to analyses (Table 1). The criteria of the CDC-
Table 2 The relationship between disability and variables
at levels 1+2
B (CI) p-value
Cognitive alteration 0.28 < 0.001
(0.16 to 0.41)







Disability variance explained from model 0.77
Multivariate linear regression analysis, final model.
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ground variables and variables reflecting autonomic car-
diovascular control were similar in the subgroup that
adhered and the subgroup that did not adhere to this
definition (Table 1). Overall, in the patient group, the
mean Fatigue severity score was 4.7 and thus close to
the upper limit (scale from 1 to 5); in addition, patients
had high scores in several other symptom domains.
In bivariate linear regression analyses, several variables
at level 1 and level 2 were significantly related to disabil-
ity. In multivariate analyses, however, only the relation-
ships to cognitive alteration, hypersensitivity, fatigue (all
level 2) and age (level 1) remained statistically significant
(Table 2, Figure 2). Thus, a high disability score is inde-
pendently related to cognitive symptoms, hypersensiti-
vity symptoms, high fatigue score, and older age. The
final model explained 77% of the variance in disability.
Cognitive alteration, in turn, was significantly related
to HR baseline, Delta HR and age (Table 3, Figure 2). In


















Figure 2 Results from the final multivariate linear regression analysesassociated with high HR at rest, enhanced HR response
during orthostatic challenge, and older age. Further-
more, hypersensitivity was significantly related to Delta
HR (ie, high hypersensitivity scores were associated with
enhanced HR response), HF-RRI baseline (high hyper-
sensitivity scores were associated with low HF-RRI), and
adherence to the CDC criteria (Table 4). Fatigue was sig-
nificantly related to gender (females tended to be more
fatigued than males) and adherence to the CDC criteria
(Table 5).
Summing up, the most important results in this study
are:
a) The disability of CFS patients is not only related to
fatigue but to other symptoms as well.
b)Altered autonomic cardiovascular control is
associated with certain symptoms.
c) The CDC definition is rather poorly associated with
disability, clinical symptoms and indices of altered
autonomic cardiovascular control in this broadly
defined CFS population.
Association between disability and other clinical
symptoms
The multivariate analyses suggest that cognitive alter-
ation, hypersensitivity, and fatigue are equally associated
with disability (Figure 2, Table 2). Of note, the mean
score for these symptoms were also quite high (Table 1).
It is generally acknowledged that an experience of cog-
nitive impairments is an essential part of CFS. Neuro-
psychological tests have revealed attenuation of executive
control function, suggesting involvement of prefrontal
cortical regions [30]. Also, cognitive behavioral therapy
(CBT) appears to be the best documented treatment stra-
tegy for CFS, in adults [31] as well as in adolescents [32],
even though opponents of CBT tend to claim that the ef-




















B = -0.02 
p = 0.05
. B=linear regression coefficient (unstandardized).
Table 3 The relationship between cognitive alteration
and variables at level 1
B (CI) p-value
HR baseline 0.03 0.010
(0.01 to 0.06)








Multivariate linear regression analyses, final model.





Adherence to CDC criteria 0.30 0.041
(0.01 to 0.59)
R2
Fatigue variance explained from model 0.32
Multivariate linear regression analyses, final model.
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results of this study suggest that improving cognitive func-
tions might have an independent, positive effect upon
patients’ functional level even when their experience of fa-
tigue is unaltered.
Hypersensitivity towards sensory stimuli is considered
a hallmark of CFS pathophysiology in a recently pro-
posed model [34]. In the latest case definition proposal,
this symptom is given less attention than several other
disease manifestations, such as symptoms of immune
alterations [35]. In this study, however, symptoms of im-
mune alterations were among the least prevalent bodily
complaints (Table 1), and were not related to disability
in the multivariate regression analysis (Table 2).
Generally, it is interesting that most symptoms were
associated with disability in bivariate analyses but did
not remain significantly associated in multivariate ana-
lyses. Although different explanations are possible, this
is congruent with theories suggesting that most CFS
symptoms are manifestations of a single, underlying
pathophysiological mechanism [12,34], and questions
the validity of highly specified, multidimensional case
definitions [35].Table 4 The relationship between hypersensitivity and
variables at level 1
B (CI) p-value
Delta HR 0.10 0.001
(0.05 to 0.16)
Adherence to CDC criteria 0.99 0.005
(0.3 to 1.7)






Multivariate linear regression analyses, final model.Association between clinical symptoms and autonomic
cardiovascular control
In this study, increased heart rate at supine rest (HR
baseline) was related to symptoms of cognitive altera-
tions (Table 3), exaggerated heart rate response during
orthostatic challenge (Delta HR) was related to cognitive
alterations, and hypersensitivity, and low heart rate va-
riability in the high-frequency range at supine rest (HF-
RRI baseline) was associated with hypersensitivity. This
finding complies with previous reports of an association
between orthostatic test results and clinical symptoms
[36-39] and suggests that head-up tilt testing might be-
come a valuable diagnostic tool in CFS; however, this
would require validation in a larger patient population,
combined with a refinement of test procedures. Also,
the results indicate, in line with scattered case reports
[40], that direct pharmaceutical treatment of cardiovas-
cular autonomic alterations might improve clinical
symptoms in CFS. This hypothesis should be tested in a
randomized controlled trial. Furthermore, such treat-
ment might be beneficial with regard to long-term car-
diovascular health, as increased basal heart rate [41], as
well as exaggerated cardiovascular responsiveness to
challenges [42] are considered risk factors for cardiovas-
cular morbidity.
Based upon our previous findings of cardiovascular
autonomic alterations, we have proposed a ‘sustained
arousal’-model of disease mechanisms in CFS [12]. This
model suggests that hyperactivity of the brain stem locus
coeruleus (LC) is a core phenomenon that promotes a
sympathetic vs. parasympathetic shift in autonomic ef-
fector systems and thus explains increased heart rate at
rest, low heart rate variability in the high-frequency
range at rest, and exaggerated heart rate responses [43].
In relation to the present study, it is noteworthy that LC
hyperactivity also attenuates cognitive abilities – in par-
ticular executive functions through the influence on pre-
frontal cortical areas [44]. Thus, the association between
HR baseline/Delta HR and cognitive alterations, as
documented in this study, seems to support the ‘sustaind
arousal’-model. Also, LC activation promotes amplifica-
tion of sensory afferent neurotransmission [45]; this
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ated heart rate response during tilt, which could be
explained from enhanced baroreceptor input to the cen-
tral reflex center [10] and symptoms of hypersensitivity.
Association between adherence to the CDC definition and
other variables
As the CDC criteria of CFS are based upon symptoms
only, associations between adherence to these criteria
and certain clinical manifestations follows directly from
the definition. What is noteworthy in this study, though,
is that these associations are rather weak (Figure 2). Fur-
thermore, adherence to the CDC criteria is not inde-
pendently associated with disability, and we did not find
any association to HR baseline, HF-RRI baseline, nor
Delta HR (Table 1). Thus, within a broadly defined
population of CFS patients, the subgroup adhering to
the CDC criteria is not characterized by a certain level
of disability, nor is this subgroup specifically related to
those indices of altered cardiovascular autonomic con-
trol that predicts clinical symptoms. The latter is in ac-
cordance with a previous study from our group, which
failed to demonstrate a relation between autonomic dys-
regulation and psychosocial load in adolescent CFS [46].
These results, in concert with other findings suggest-
ing that all chronic fatigue states share a relatively
stereotyped set of symptoms [47], add to the concerns
about the validity of the CDC definition, in particularly
among adolescents [18-20]. Indeed, a large epidemio-
logical survey suggests that CFS should be lumped to-
gether with several other ‘functional’ disorders, such as
fibromyalgia and irritable bowel syndrome [48]. The
controversies regarding diagnostic criteria constitute a
great challenge for the CFS scientific community. One
approach to clarify this issue in further studies would be
to apply wider inclusion criteria than has been common
so far, and thereafter perform subgroup analyses based
on different case definitions [21].
Study limitations
A strong limitation of this study is the limited number
of participants, which particularly weakens the statistical
power in multivariate analyses. Also, we have insufficient
data regarding the participants that dropped out of the
study, making the generalizability of the results more
uncertain. The fatigue severity scale has a strong ceiling
effect and was not normally distributed; this may have
lead to underestimation of the associations involving this
variable. The disability score has not been formally vali-
dated; although we consider the face validity to be reason-
able, further studies in the field should use formally
validated instruments, such as the Functional Disability In-
ventory [49]. As this was an exploratory study, we did not
adjust the p-values for multiple statistical testing; it shouldbe noted, however, that the majority of p-values were far
beyond the level of significance and thus would probably
have remained significant despite rigorous adjustments.
Of note, the documented associations between auto-
nomic cardiovascular control, clinical symptoms, and
disability are not proof of causality. Also, our three-level
model should be regarded as a framework for explora-
tive analyses only. Generally, the interactions might be
far more complex than what we have shown here; inves-
tigating this possibility would require a larger number of
participants and a prospective design allowing repeated
measurements.
Conclusions
In this exploratory study of adolescent CFS patients, dis-
ability was associated with cognitive alterations, hyper-
sensitivity, and fatigue; cognitive alterations and
hypersensitivity were associated with indices of altered
cardiovascular autonomic control; and adherence to the
CDC-criteria was poorly associated with other variables.
These associations, which may have an important impact
on clinical handling, should be further explored in a
large-scale clinical study.
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